Conorfamide-As2b is a conorfamide-family peptide exhibiting amidated C-terminus and residues suitable for neuromodulatory receptor binding. Compact structure and specific side-chain pattern support selective recognition in neuronal assays. Researchers evaluate its conformational landscape and activity using electrophysiology. Applications include neuropeptide-signaling studies, toxin-motif analysis, and receptor-mapping efforts.
CAT No: R2739
Conorfamide-As2b is a specialized peptide derived from the venom of marine cone snails, recognized for its unique structural characteristics and its ability to modulate neural signaling pathways. As a member of the conorfamide family, this compound features a distinct amino acid sequence that allows it to interact with specific ion channels and receptors, making it a valuable tool for neurobiological research. Its synthetic accessibility and stability under laboratory conditions further enhance its utility in experimental settings. Researchers are increasingly interested in Conorfamide-As2b due to its selective bioactivity and potential to elucidate complex neurophysiological processes. The peptide's mechanism of action involves targeting neuronal circuits, providing insights into synaptic transmission and receptor modulation.
Neuroscience research: In the field of neuroscience, Conorfamide-As2b serves as a powerful molecular probe to investigate the function of ion channels and G protein-coupled receptors within neural tissues. By selectively binding to these targets, it enables researchers to dissect the underlying mechanisms of synaptic communication and neuronal excitability. Its application in electrophysiological studies facilitates the mapping of neural network activity and the identification of novel modulatory sites. As a result, this peptide is instrumental in advancing our understanding of neural signaling pathways and their role in various physiological states.
Pharmacological screening: Conorfamide peptides, including As2b, are frequently employed in high-throughput pharmacological assays to identify new ligands or modulators for neural receptors. Their specificity and defined activity profiles make them ideal for screening compound libraries and characterizing drug-receptor interactions. By serving as a reference or control compound, Conorfamide-As2b aids in the validation of assay systems and the optimization of experimental conditions. This application accelerates the discovery of novel neuroactive agents and supports the development of targeted therapeutics.
Structure-activity relationship studies: The unique sequence and conformational properties of this conorfamide variant make it an excellent candidate for structure-activity relationship (SAR) investigations. Researchers utilize Conorfamide-As2b to systematically modify amino acid residues and assess the impact on biological activity. These studies provide critical insights into the molecular determinants of receptor binding and functional selectivity. The resulting data inform the rational design of new peptides with enhanced potency or selectivity, furthering the field of peptide engineering.
Comparative toxinology: In toxinology research, As2b is valuable for comparative studies aimed at understanding evolutionary adaptations in venomous species. By analyzing the structural and functional diversity of conorfamides across different cone snail species, scientists can elucidate the molecular evolution of venom components. These investigations reveal how subtle sequence variations contribute to the specificity and potency of peptide toxins. Conorfamide-As2b thus serves as a reference point for comparative analyses and evolutionary biology research.
Peptide-based tool development: The distinctive properties of this peptide have inspired its use in the development of novel research tools and molecular probes. By harnessing its selective receptor interactions, scientists create labeled or modified derivatives for imaging studies, receptor localization, or targeted delivery applications. Such tools expand the experimental repertoire available to neurobiologists and pharmacologists, enabling more precise manipulation and visualization of neural pathways. The ongoing exploration of Conorfamide-As2b and its analogs continues to drive innovation in peptide-based research methodologies and the broader field of neuropharmacology.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Cationic cell-penetrating peptides are potent furin inhibitors
4. Myotropic activity of allatostatins in tenebrionid beetles
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More